Royal Society of Chemistry, Biomaterials Science, 13(8), p. 3720-3729, 2020
DOI: 10.1039/d0bm00556h
Export citation
Search in Google Scholar
Full text: Unavailable
v6 Fab-PLGA-PEG NPs have the potential to deliver intracellularly bevacizumab in CD44v6 expressing cancer cells.